(Q46074461)

19 December 2017

title

Improving the accuracy and precision of cognitive testing in mild dementia (English)

1 reference

19 December 2017

main subject

accuracy and precision

1 reference

Wiesje M van der Flier

3

0 references

Philip Scheltens

9

object named as

Philip Scheltens

1 reference

19 December 2017

4

Jos van Campen

1 reference

19 December 2017

author name string

Hans Wouters

1

1 reference

19 December 2017

Bregje Appels

2

1 reference

19 December 2017

Martin Klein

5

1 reference

19 December 2017

Aeilko H Zwinderman

6

1 reference

19 December 2017

Ben Schmand

7

1 reference

19 December 2017

Willem A van Gool

8

1 reference

19 December 2017

Robert Lindeboom

10

1 reference

19 December 2017

publication date

30 December 2011

1 reference

19 December 2017

Journal of the International Neuropsychological Society

published in

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

314-322

1 reference

19 December 2017

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

A neuropsychological test battery for use in Alzheimer disease clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Revising the ADAS-cog for a more accurate assessment of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Reversible dementia in elderly patients referred to a memory clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Endpoints for trials in Alzheimer's disease: a European task force consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Visual association test to detect early dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

The relation of the trail making test to organic brain damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617711001755

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1355617711001755

1 reference

19 December 2017

1 reference

19 December 2017